Our news Archives
Emergent Technologies, Inc. announced today that it has hired seasoned business development professional and immunology expert Gregory Frank, Ph.D. as President of Pure Protein, LLC, a leading developer of soluble HLA protein reagents for use in therapeutic and diagnostic applications; and Pure MHC, LLC, developer of a proprietary technology used to discover novel targets to treat infectious disease and cancer.
Pure MHC, LLC, a provider of MHC-based diagnostics and therapeutics, and Catalent Pharma Solutions, the global leader in drug development solutions and advanced delivery technologies for pharmaceutical, biologic and consumer health products, today announced the signing of a product development agreement.
HLA Technology Leaders Join Forces to Develop Novel Antibody Screening Solution.
Pure Protein, L.L.C. (PURE) has announced the company will deliver twelve oral and print poster presentations at the Annual Meeting of the American Society of Histocompatibility and Immunogenetics (ASHI) in Puerto Rico, October 8th through October 12th.
Pure will be bringing a contingent of 15 scientists, associates and corporate officers to the 38th ASHI Annual Meeting. The team will be giving a number of oral and poster presentation of the latest work and achievements completed in the PURE labs this year. One of these presentations has been already judged the Runner-Up Best Presentation. The titles of the PURE Presentations are listed here: